BACTERIA INDUCE RELEASE OF PLATELET-ACTIVATING-FACTOR (PAF) FROM POLYMORPHONUCLEAR NEUTROPHIL GRANULOCYTES - POSSIBLE ROLE FOR PAF IN PATHOGENESIS OF EXPERIMENTALLY INDUCED BACTERIAL PNEUMONIA

被引:15
作者
MAKRISTATHIS, A [1 ]
STAUFFER, F [1 ]
FEISTAUER, SM [1 ]
GEORGOPOULOS, A [1 ]
机构
[1] TECH UNIV VIENNA,INST APPL BOT TECH MICROSCOPY & ORGAN NAT PROD,A-1090 VIENNA,AUSTRIA
关键词
D O I
10.1128/IAI.61.5.1996-2002.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of platelet-activating factor (PAF) as mediator of the endotoxin shock and endotoxin-dependent tissue injury has been examined. The ability of opsonized bacteria to stimulate the release of PAF from human polymorphonuclear neutrophil granulocytes was evaluated by measuring both the activity and the amount of the mediator released in the supernatant of the cell-bacteria reaction in vitro. There was no significant difference between gram-positive and gram-negative bacteria in the ability to release PAF from neutrophils. However, preincubation of the cells with the specific PAF receptor antagonist WEB 2170 decreased release of PAF from the cells. Furthermore, a possible protective effect of the PAF antagonist was examined during experimentally induced pneumonia with Klebsiella pneumoniae in NMRI mice. Oral treatment of mice with WEB 2170, followed by infection with the microorganisms, resulted in a considerable increase in the animals' survival (53 to 73%) compared with the control group (40%); this increase corresponded with a decrease in the CFU per gram of lung tissue. These findings indicate an important role of PAF in the pathogenesis of pneumonia in mice.
引用
收藏
页码:1996 / 2002
页数:7
相关论文
共 37 条
[1]   LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J].
BENVENISTE, J ;
HENSON, PM ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1356-+
[2]   THE ACTIONS OF PAF-ACETHER (PLATELET-ACTIVATING FACTOR) ON GUINEA-PIG ISOLATED HEART PREPARATIONS [J].
BENVENISTE, J ;
BOULLET, C ;
BRINK, C ;
LABAT, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (01) :81-83
[3]   PLATELET-ACTIVATING FACTOR (PAF)-DEPENDENT BIOCHEMICAL, MORPHOLOGIC, AND PHYSIOLOGIC RESPONSES OF HUMAN-PLATELETS - DEMONSTRATION OF TRANSLOCATION OF PROTEIN KINASE-C ASSOCIATED WITH PROTEIN-PHOSPHORYLATION [J].
BLOCK, LH ;
ABRAHAM, WM ;
GROSCURTH, P ;
QIAO, BY ;
PERRUCHOUD, AP .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1989, 1 (04) :277-288
[4]  
BRAQUET P, 1989, J LIPID MEDIATOR, V1, P75
[5]  
BREMM KD, 1988, ZENTRALBL BAKTERIO S, V17, P103
[6]  
CAMMUSI G, 1981, IMMUNOLOGY, V42, P191
[7]  
CAMMUSI G, 1981, INT ARCH ALLER A IMM, V64, P25
[8]   BRONCHIAL AND VASCULAR EFFECTS OF PAF IN THE RAT ISOLATED LUNG ARE COMPLETELY BLOCKED BY WEB-2086, A NOVEL SPECIFIC PAF ANTAGONIST [J].
CASALSSTENZEL, J ;
FRANKE, J ;
FRIEDRICH, T ;
LICHEY, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (04) :799-802
[9]   EFFECTS OF WEB-2086, A NOVEL ANTAGONIST OF PLATELET-ACTIVATING-FACTOR, IN ACTIVE AND PASSIVE ANAPHYLAXIS [J].
CASALSSTENZEL, J .
IMMUNOPHARMACOLOGY, 1987, 13 (02) :117-124
[10]   BENEFICIAL EFFECT OF A PLATELET-ACTIVATING FACTOR ANTAGONIST, WEB-2086, ON ENDOTOXIN-INDUCED LUNG INJURY [J].
CHANG, SW ;
FERNYAK, S ;
VOELKEL, NF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (01) :H153-H158